SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Kairos Pharma Files SEC Form

Kairos Pharma submits regulatory filing with the SEC. The filing is a DEF 14A statement.

0001962011

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.